🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to evaluate the reactogenicity, safety and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-02-02
Trial ID
NCT05169905
Treatments Being Tested
Assessing the safety, immunogenicity and ex-vivo efficacy of two transmissi...
Status
Active Not Recruiting
Location
Institut des Sciences et Techniques (INSTech)
Start Date
2025-07-07
Trial ID
NCT06549257
Treatments Being Tested
This is an open label, phase 1 clinical trial of an intra-dermal booster do...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-10
Trial ID
NCT05430958
Treatments Being Tested
This study is a single center , randomized ,controlled and open-label phase...
Status
Completed
Location
Beijing Centers for Diseases Control and Prevention
Start Date
2021-10-15
Trial ID
NCT05499351
The purpose of the study is to determine the safety of and immune response ...
Status
Completed
Location
San Francisco Vaccine and Prevention CRS
Start Date
2006-01
Trial ID
NCT00141024
Treatments Being Tested
This phase 1/2 study will evaluate the safety, reactogenicity and immunogen...
Status
Active Not Recruiting
Location
Fusion Clinical Research
Start Date
2025-06-18
Trial ID
NCT06984094
Treatments Being Tested
The purpose of this follow-up study is to evaluate the persistence of antib...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-01-31
Trial ID
NCT01738477
Treatments Being Tested
This study will evaluate whether administration of two investigational mala...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-08-10
Trial ID
NCT01366534
GSK Biologicals' dTpa vaccine has recently been approved by the US Food and...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-07-13
Trial ID
NCT00346073
This Phase 1 study will evaluate the safety, tolerability, and immune respo...
Status
Not Yet Recruiting
Location
Bridge HIV CRS Site# 30305
Start Date
2026-09-10
Trial ID
NCT07757802
Treatments Being Tested